Who owns VIVOS THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Vivos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Vivos Therapeutics stock

Who bought or sold VIVOS THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Connective Capital Management 200k $620k 100% Sep 2025
 View chart
Strategic Wealth Designers 100k $310k 100% Sep 2025
 View chart
Vanguard Group 92k $284k 115% Sep 2025
 View chart
Geode Capital Management 53k $165k -8% Sep 2025
 View chart
National Asset Management 44k $135k -37% Sep 2025
 View chart
DRW Holdings 42k $129k 100% Sep 2025
 View chart
Commonwealth Equity Services 41k $127k 0% Sep 2025
 View chart
Renaissance Technologies 39k $122k 100% Sep 2025
 View chart
BlackRock 28k $86k 100% Sep 2025
 View chart
State Street Corporation 25k $77k 111% Sep 2025
 View chart
Northern Trust 13k $39k 0% Sep 2025
 View chart
Advisor Group Holdings 6.6k $21k 726% Sep 2025
 View chart
Tower Research Capital 2.8k $8.7k 462% Sep 2025
 View chart
Morgan Stanley 1.1k $3.4k 100% Jun 2025
 View chart
Signature 547.00 $1.7k 0% Sep 2025
 View chart
Ronald Blue Trust 160.00 $496.000000 0% Sep 2025
 View chart
UBS Group 102.00 $315.996000 -100% Sep 2025
 View chart
Kozak & Associates 49.00 $117.002200 0% Sep 2025
 View chart
FMR 40.00 $124.000000 100% Sep 2025
 View chart
Global Retirement Partners 23.00 $71.001000 0% Sep 2025
 View chart
Royal Bank of Canada 4.00 $0 0% Sep 2025
 View chart

Who sold out of Vivos Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
XTX Topco Jun 2025 21k $65k
Credit Agricole Mar 2025 2.4k $6.7k
Raymond James Financial Jun 2025 74.00 $234.002800
Steward Partners Investment Advisory Jun 2025 8.00 $25.000000